Kinetic modulatory profiling identifies regulators of ferroptosis, including the FDA-approved drug bazedoxifene, which acts in an off-target manner as a radical trapping antioxidant while mTOR inhibitors increased resistance to ferroptosis.
- Megan Conlon
- Carson D. Poltorack
- Scott J. Dixon